Schedule 13G ownership disclosure

Edgewise Therapeutics Inc

Common Stock · CUSIP: 28036F105

Event date: 2024-12-31

Filing-level shares
4,983,940
Percent of class
5.3%
  • JANUS HENDERSON GROUP PLC

    Shares: 4,983,940 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000039
Form type
SCHEDULE 13G
Filer
Edgewise Therapeutics, Inc.
CIK
CIK 1710072
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub